SEROTONINERGIC TERMINAL TRANSPORTERS ARE DIFFERENTIALLY AFFECTED IN PARKINSONS-DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY - AN AUTORADIOGRAPHIC STUDY WITH [H-3] CITALOPRAM
G. Chinaglia et al., SEROTONINERGIC TERMINAL TRANSPORTERS ARE DIFFERENTIALLY AFFECTED IN PARKINSONS-DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY - AN AUTORADIOGRAPHIC STUDY WITH [H-3] CITALOPRAM, Neuroscience, 54(3), 1993, pp. 691-699
Receptor autoradiography with [H-3]citalopram as ligand was used to st
udy the distribution of serotonin uptake binding sites in post mortem
brain tissues from patients with Parkinson's disease, progressive supr
anuclear palsy and from age-matched controls. Significant decreases in
[H-3]citalopram binding sites were found in the cerebral cortex of pa
tients with Parkinson's disease and progressive supranuclear palsy. De
nsities of [H-3]citalopram binding sites were significantly reduced in
all components of the basal ganglia of Parkinson's disease but only i
n the head of caudate nucleus of progressive supranuclear palsy patien
ts. The density of [H-3]citalopram binding sites in the raphe nuclei o
f Parkinson's disease was comparable to control values. Our results su
ggest that serotoninergic terminals are differentially affected in Par
kinson's disease and in progressive supranuclear palsy.